Check out your Company Bowl for anonymous work chats.
We are proud that we have been selected as a winner of Deloitte Canada’s #BestManaged Companies program for the sixth year in a row. Congratulations to all our fellow winners!
We are grateful to be selected as an I.D.E.A.L Bioscience Employer by BioTalent Canada for the second year in a row! This designation recognizes organizations in the Canadian bio-economy that are embodying the inclusion, diversity, equity, and accessibility leadership (IDEAL) principles and best practices. We want to thank all of our colleagues as this recognition is a testament to their commitment to making STEMCELL an inclusive workplace with a strong culture of belonging. #DEI #CdnInnovation
We are proud that we have been selected as a winner of Canada's Best Managed Companies program for the third year in a row. Congratulations to all of our fellow winners!
STEMCELL Technologies has been awarded Canadian Business' inaugural Global Business Award, which celebrates a company that has made impressive strides in international business. STEMCELL was selected for this award because it has "the most thought-out strategy for expansion and the reach to prove it." This award recognized a company that defies setbacks in its global push and possesses the management skills to flourish in a turbulent economy. The Global Award accompanies our 2020 Growth 500 ranking of #313.
The Healthcare Technology Report has announced the Top 25 Women Leaders in Biotechnology of 2020. Recognized on the list from STEMCELL Technologies are Joan Sheehan, Executive Vice President, Global Sales and Helen Sheridan, Senior Vice President, Human Resources. Joan joined STEMCELL in its infancy. Over the next decade, driven by CEO Allen Eavesâ unrelenting pursuit of scientific knowledge and dedication to quality, STEMCELL saw annual growth of 15-30%. Having taken on various roles in the company, including overall responsibility for global Sales starting in 2004, Joan is seen has having played a large part in this success. Helen has been with STEMCELL for five years, bringing with her an immense portfolio of business experience spanning over 25 years. She traveled the world from a very young age, and as a result brings with her a strong respect for the diversity of human experience represented in organizations. Her personal purpose is to help build organizations in which people can grow and thrive, and to deliver business results they can be proud of for their entire careers.
STEMCELL Technologies is excited to be participating in the "SARS-CoV-2 Study for Eased Restrictions in British Columbia" (SAfER) project, a $1.2 million return-to-work study that aims to support decision making around relaxing restrictions and managing work environments as society begins the process of re-opening during COVID-19. The SAfER study, supported by Genome BC, Genome Canada, and industry partners, will track and collect data over time on infection, immunity, contacts, and clinical symptoms for 1,500 volunteer employees from STEMCELL and various BC-based biotechnology companies, as well as SFU and UBC. The data from the project, collected in controlled settings, will be available in real time to help inform public health decisions that lead to positive outcomes.
Rapid Response
#COVID19 Research
Winner of Canada's Best Managed Companies 2019
